Expert consensus on neoadjuvant treatment of breast cancer in China (2021 edition)
Neoadjuvant therapy has become one of the standard treatments in early breast cancer. In 2019, China breast cancer neoadjuvant therapy expert group discussed and expounded the purpose, indication, evaluation criteria, surgical operation principles and the treatment strategy of neoadjuvant therapy. W...
| Autore principale: | |
|---|---|
| Natura: | Articolo |
| Lingua: | English |
| Pubblicazione: |
Editorial Office of China Oncology
2022-01-01
|
| Serie: | Zhongguo aizheng zazhi |
| Soggetti: | |
| Accesso online: | http://www.china-oncology.com/fileup/1007-3639/PDF/1643099040828-1468604485.pdf |
| Riassunto: | Neoadjuvant therapy has become one of the standard treatments in early breast cancer. In 2019, China breast cancer neoadjuvant therapy expert group discussed and expounded the purpose, indication, evaluation criteria, surgical operation principles and the treatment strategy of neoadjuvant therapy. We further updated and discussed the clinical implementations and treatment principles of neoadjuvant therapy. |
|---|---|
| ISSN: | 1007-3639 |